Gershon Capital provides direct investment and deal syndication for emerging healthcare and life science companies. The firm provides both strategic and quantitative services to identify new healthcare investment opportunities, lead due diligence on prospective investments, provide technical, scientific and financial analysis, arrange investor meetings, negotiate with syndicated investors and counsel, and structure and close the transaction.
